Development and Sales Milestone Payment Obligations
First written in FY2017. 6 of 10 entries say "Mitigated", first in FY2018. Latest entry: FY2026.
Ono Pharmaceutical moved to the "Worse" side of this theme in 2026.
0 other companies' latest entry also says "Worsened".
- FY2026WorsenedAnnual report
「The amount of milestone payments that the Group may be required to pay within the next 3 years was ¥7,667 million and ¥11,099 million at the end of the previous fiscal year and the end of the fiscal year, respectively.」
Potential milestone payments within the next 3 years increased from ¥7,667 million to ¥11,099 million. - FY2025MitigatedAnnual report
「The amount of milestone payments that the Group may be required to pay within the next 3 years was ¥8,349 million and ¥7,667 million at the end of the previous fiscal year and the end of the fiscal year, respectively.」
Potential milestone payments within the next 3 years decreased from ¥8,349 million to ¥7,667 million. - FY2024MitigatedAnnual report
「The amount of milestone payments that the Group may be required to pay within the next 3 years was ¥13,584 million and ¥8,349 million at the end of the previous fiscal year and the end of the fiscal year, respectively.」
Potential milestone payments within the next 3 years decreased from ¥13,584 million to ¥8,349 million. - FY2023WorsenedAnnual report
「The amount of milestone payments that the Group may be required to pay within the next 3 years was ¥11,964 million and ¥13,584 million at the end of the previous fiscal year and the end of the fiscal year, respectively.」
Potential milestone payments within the next 3 years increased from ¥11,964 million to ¥13,584 million. - FY2022MitigatedAnnual report
「The amount of milestone payments that the Group may be required to pay within the next 3 years was ¥14,661 million and ¥11,964 million at the end of the previous fiscal year and the end of the fiscal year, respectively.」
Potential milestone payments within the next 3 years decreased from ¥14,661 million to ¥11,964 million. - FY2021WorsenedAnnual report
「The amount of milestone payments that the Group may be required to pay within the next 3 years was ¥11,760 million and ¥14,661 million at the end of the previous fiscal year and the end of the fiscal year, respectively.」
Potential milestone payments within the next 3 years increased from ¥11,760 million to ¥14,661 million, expanding potential payment exposure. - FY2020MitigatedAnnual report
「The amount of milestone payments that the Group may be required to pay within the next 3 years was ¥18,158 million and ¥11,760 million at the end of the previous fiscal year and the end of the fiscal year, respectively.」
Potential milestone payments within the next 3 years decreased from ¥18,158 million to ¥11,760 million. - FY2019MitigatedAnnual report
「The amount of milestone payments that the Group may be required to pay within the next 3 years was ¥19,359 million and ¥18,158 million at the end of the previous fiscal year and the end of the fiscal year, respectively.」
Potential milestone payments within the next 3 years decreased from ¥19,359 million to ¥18,158 million. - FY2018MitigatedAnnual report
「The amount of milestone payments that the Group may be required to pay within the next 3 years was ¥23,767 million and ¥19,359 million at the end of the previous fiscal year and the end of the fiscal year, respectively.」
Development and sales milestone payment obligations within the next 3 years decreased from ¥23,767 million to ¥19,359 million. - FY2017First statedAnnual report
「The Group has milestone payments linked to the success of development projects and the achievement of specified sales targets. As of the end of the fiscal year, the amount of milestone payments that the Group may be required to pay within the next 3 years was ¥23,767 million.」
For the first time, the company quantified its potential exposure as the maximum milestone payments that may be required within the next 3 years in connection with the success of development projects and the achievement of sales targets.